US Patent Issued to Rutgers, The State University of New Jersey, Plumeria Therapeutics on June 3 for "Method and kit for CCR2 expression profiling and disease stratification" (New Jersey Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,958, issued on June 3, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.) and Plumeria Therapeutics Inc. (Plainsboro, N.J.).

"Method and kit for CCR2 expression profiling and disease stratification" was invented by Lei Yu (Belle Mead, N.J.) and Thomas P. Richardson (West Windsor, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating disease include measuring a CCR2 profile of a patent, selecting a CCR2 antagonist based on the CCR2 profile of the patient, and administering the CCR2 antagonist to the patient. Methods for stratifying one or more patients for pain medication based on a CCR2 profile include...